Efficacy of stress-rest 99mTc-MiBi myocardial spet in the predicition of contractile recovery after revascularization. Results of the spanish multicentric trial;Eficacia del SPET miocárdico esfuerzo-reposo con 99mTc-MiBi en la predicción de la recuperabilidad de la función contráctil posrevascularización. Resultados del protocolo multicéntrico español

Revista Espanola de Cardiologia

Volumn 53, Issue 7, 2000, Pages 903-910

  Candell Riera, Jaume ^a   Castell Conesa, Joan ^a   González, José Manuel ^a   Rosselló Urgell, José ^a  

^a NONE

Author keywords

Coronary disease; Hybernation; Revascularization; Scintigraphy; Tomography

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BLOOD POOL SCINTISCANNING; CLINICAL TRIAL; FEMALE; HEART; HEART CONTRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTON EMISSION TOMOGRAPHY; PREDICTION; STRESS; EXERCISE TEST; GATED IMAGING; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EXERCISE TEST; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034223162     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/10477     Document Type: Article

References (40)

1. Braunwald E, Rutheford JD. Reversible ischemic left ventricular dysfunction: evidence for the «hibernating myocardium». J Am Coll Cardiol 1986; 8: 1467-1470.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
3. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994; 90: 2687-2694.
4. Brunken R, Tillisch J, Schwaiger M, Child JS, Marshall R, Maldenkern M et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986; 73: 951-963.
5. Tillisch J, Brunken R, Marshall R, Schwaiger M, Maldenkern M, Pheps M et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
6. Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J. Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987; 10: 557-567.
7. Henes CG, Bergmann SR, Walsh MN, Sobel BE, Geltman EM. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and Carbon-11 acetate. J Nucl Med 1989; 30: 1489-1499.
8. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565-578.
9. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
10. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary atery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-Fluorodeoxyglucose. Circulation 1991; 83: 26-37.
11. Dilsizian V, Freedman NMT, Bacharach SL, Perrone-Filardi P, Bonow RO. Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992; 85: 627-634.
12. 99mTc-sestamibi with thallium-201 reinjection and (18F)fluorodeoxyglucose. Circulation 1994; 89: 578-587.
13. Iskandrian AS, Hakki A, Kane SA, Goel IP, Mundth ED, Hakki A et al. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. Am J Cardiol 1983; 51: 1312-1316.
14. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992; 33: 1925-1930.
15. Rocco TP, Dilsizian V, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest. II. Relation to clinical markers of potential viability. J Am Coll Cardiol 1989; 14: 1678-1684.
16. Kiat H, Herman DS, Maddahi J, Yang DL, Van Train K, Rozanski A et al. Late reversibility of tomographic miocardial thallium-201 defects: an accurate predictor of myocardial viability. J Am Coll Cardiol 1988; 12: 1456-1463.
17. Inglese E, Bambrilla M, Dondi M, Pieri PL, Bisi G, Cannizzaro G et al. Assessment of myocardial viability after thallium-201 reinjection or rest-redistribution imaging: a multicenter study. J Nucl Med 1995; 36: 555-563.
18. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1630-1641.
19. Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 1993; 88: 941-952.
20. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Rest-injected tallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991; 32: 1718-1724.
21. Rocco TP, Dilsizian V, McKusick KA, Fishman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest «reinjection» imaging for the detection of viable myocardium. Am J Cardiol 1990; 66: 158-163.
22. Dilsizian V, Rocco TP, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest. I. Relation to severity of coronary artery stenosis. J Am Coll Cardiol 1989; 14: 1678-1684.
23. 99mTc-Sestamibi. Circulation 1994; 89: 2552-2561
24. Altehoefer C, Vom Dhal J, Buell U, Uebis R, Kleinhans E, Hanrath P. Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery deisease. Eur J Nucl Med 1994; 21: 37-45.
25. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutylisonitrile. J Nucl Med 1992; 33: 505-511.
26. Dondi M, Tartagni F, Fallani F, Fanti S, Marengo M, DiTomaso I et al. A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography: possible implications for myocardial viability detection in infarcted patients. Eur J Nucl Med 1993; 20: 26-31.
27. 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med 1992; 19: 334-342.
28. Altehoefer C, Von Dahl J, Biedermann M, Uebis R, Beilin I, Sheehan F et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994; 35: 569-574.
29. Sawada SG, Almman KC, Muzik O, Beanlands RS, Wolfe ER, Gross M et al. Positron emission tomography detects evidence of viability in rest Technetium-99m Sestamibi defects. J Am Coll Cardiol 1994; 23: 92-98.
30. Castell J, Candell-Riera J, Roselló-Urgell J, Fraile López-Amor M, Hornero-Sos F, Aguadé-Bruix S et al. Valoración de la viabilidad miocárdica mediante tecnecio-99m isonitrilo y talio-201. Resultados del protocole multicéntrico español. Rev Esp Cardiol 1997; 50: 320-330.
31. Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995; 92: 3436-3444.
32. Christian TF, Miller TD, Hogde DO, Orszulak TA, Gibbons RJ. An estimate of the prevalence of reversible left ventricular dysfunction in patients referred for coronary artery bypass surgery. J Nucl Cardiol 1997; 4: 140-146.
33. Candell Riera J. Utilidad de la ventriculografía isotópica en el seguimiento de la disfunción ventricular izquierda. Rev Esp Cardiol 1992; 45: 386-387.
34. Iskandrian AS. Myocardial viability: unresolved issues. J Nucl Med 1996; 37: 794-797.
35. Chaitman BR, Jaffe AS. What is the true perioperative myocardial infarction rate? Does anyone know for sure? The need for clarification. Circulation 1995; 91: 1609-1610.
36. Candell-Riera J, de la Hera JM, Santana-Boado C, Castell-Conesa J, Aguadé-Bruix S, Bermejo B et al. Eficacia diagnóstica de la tomogammagrafía miocárdica en la detectión de reestenosis coronaria postangioplastia. Rev Esp Cardiol 1998; 51: 648-654.
37. 99mTc-Sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation 1996; 94: 1010-1017.
38. 99mTc-Sestamibi tomography before coronary bypass graft surgery. Correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997; 96: 2892-2898.
39. Maes AF, Borgers M, Flameng W, Nuyts JL, van de Werf F, Ausma JJ et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m-sestamibi SPECT. Correlation with histologic and positron emission tomographyc studies and functional follow-up. J Am Coll Cardiol 1997; 29: 62-68.
40. Candell Riera J, Aguadé Bruix S, Castell Conesa J, Cortadellas Angel J. Isonitrilos marcados con tecnecio-99m frente a talio-201 en la enfermedad coronaria. Rev Esp Cardiol 1994; 47 (Supl 4): 101-115.